High melatonin levels are related to spinal ossification in patients with ankylosing spondylitis

References

• Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379–90.
   PubMed Web of Science ®Google Scholar
• Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010;6(7):399–405.
   PubMed Web of Science ®Google Scholar
• Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010;6(2):75–81.
   PubMed Web of Science ®Google Scholar
• Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep. 2009;61(3):383–410.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab. 2003;17(2):273–85.
   PubMed Web of Science ®Google Scholar
• Lin GJ, Huang SH, Chen SJ, Wang CH, Chang DM, Sytwu HK. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. IJMS. 2013;14(6):11742–66.
   Google Scholar
• Garcia-Mauriño S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol. 1997;159(2):574–81.
   PubMed Web of Science ®Google Scholar
• García-Mauriño S, Pozo D, Calvo JR, Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res. 2000;29(3):129–37.
   PubMed Web of Science ®Google Scholar
• Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol. 2017;2017:1835195.
   PubMed Web of Science ®Google Scholar
• Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM. Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res. 2000;28(4):193–202.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Reiter RJ, Qi WB, Zhang M, Weintraub ST, et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta. 1999;1472(1–2):206–14.
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Melatonin and the skeleton. Osteoporos Int. 2013;24(12):2919–27.
   PubMed Web of Science ®Google Scholar
• Maria S, Witt-Enderby PA. Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res. 2014;56(2):115–25.
   PubMed Web of Science ®Google Scholar
• Radio NM, Doctor JS, Witt-Enderby PA. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res. 2006;40(4):332–42.
   PubMed Web of Science ®Google Scholar
• Maria S, Samsonraj RM, Munmun F, Glas J, Silvestros M, Kotlarczyk MP, et al. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. J Pineal Res. 2018;64(3):e12465.
   Web of Science ®Google Scholar
• Kim HJ, Kim HJ, Bae MK, Kim YD. Suppression of osteoclastogenesis by melatonin: a melatonin receptor-independent action. Int J Mol Sci. 2017;18(6):1142.
   Web of Science ®Google Scholar
• Ping Z, Wang Z, Shi J, Wang L, Guo X, Zhou W, et al. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Acta Biomater. 2017;62:362–71.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.
   PubMed Web of Science ®Google Scholar
• Zhao ZY, Xie Y, Fu YR, Bogdan A, Touitou Y. Aging and the circadian rhythm of melatonin: a cross-sectional study of Chinese subjects 30–110 yr of age. Chronobiol Int. 2002;19(6):1171–82.
   PubMed Web of Science ®Google Scholar
• Senna MK, Olama SM, El-Arman M. Serum melatonin level in ankylosing spondylitis: is it increased in active disease? Rheumatol Int. 2012;32(11):3429–33.
   PubMed Web of Science ®Google Scholar
• Senel K, Baykal T, Melikoglu MA, Erdal A, Karatay S, Karakoc A, et al. Serum melatonin levels in ankylosing spondilitis: correlation with disease activity. Rheumatol Int. 2011;31(1):61–3.
   PubMed Web of Science ®Google Scholar
• Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol. 2010;80(12):1844–52.
   PubMed Web of Science ®Google Scholar
• Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem. 1999;274(31):22041–7.
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res. 2015;59(2):221–9.
   PubMed Web of Science ®Google Scholar
• Agas D, Lacava G, Sabbieti MG. Bone and bone marrow disruption by endocrine-active substances. J Cell Physiol. 2018;234(1):192–213.
   PubMed Web of Science ®Google Scholar
• Karsenty G. Transcriptional regulation of osteoblast differentiation during development. Front Biosci. 1998;3(4):d834–7.
   PubMedGoogle Scholar
• Lee EG, Sung MS, Yoo HG, Chae HJ, Kim HR, Yoo WH. Increased RANKL-mediated osteoclastogenesis by interleukin-1β and endoplasmic reticulum stress. Joint Bone Spine. 2014;81(6):520–6.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Yamasaki S, Oi K, Kuranobu T, Nojima T, Miyaki S, et al. IL-1β enhances Wnt signal by inhibiting DKK1. Inflammation. 2018;41(5):1945–54.
   PubMed Web of Science ®Google Scholar
• Sonomoto K, Yamaoka K, Oshita K, Fukuyo S, Zhang X, Nakano K, et al. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Arthritis Rheum. 2012;64(10):3355–63.
   PubMedGoogle Scholar
• Liu X, Gong Y, Xiong K, Ye Y, Xiong Y, Zhuang Z, et al. Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res. 2013;55(1):14–25.
   PubMed Web of Science ®Google Scholar
• Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550(7677):475–80.
   PubMed Web of Science ®Google Scholar